Jianyou Pharmaceutical (603707.SH) has announced that its subsidiary, Hong Kong Jianyou Industrial Co., Ltd. ("Hong Kong Jianyou"), recently received an ANDA approval notice (ANDA number: 213131) from the US Food and Drug Administration ("US FDA") for Vitamin B1 Injection 200mg/2mL (100mg/mL).

The newly approved product further enriches the company's international product pipeline and strengthens its international market presence.

If subsequent launch and sales in the US market are pursued, it is expected to have a positive impact on the company's operating performance.